Literature DB >> 25300616

Inflammation-driven carcinogenesis is mediated through STING.

Jeonghyun Ahn1, Tianli Xia1, Hiroyasu Konno1, Keiko Konno1, Phillip Ruiz2, Glen N Barber1.   

Abstract

Chronic stimulation of innate immune pathways by microbial agents or damaged tissue is known to promote inflammation-driven tumorigenesis by mechanisms that are not well understood. Here we demonstrate that mutagenic 7,12-dimethylbenz(a)anthracene (DMBA), cisplatin and etoposide induce nuclear DNA leakage into the cytosol that intrinsically activates stimulator of interferon genes (STING)-dependent cytokine production. Inflammatory cytokine levels are subsequently augmented in a STING-dependent extrinsic manner by infiltrating phagocytes purging dying cells. Consequently, STING(-/-) mice, or wild-type mice adoptively transferred with STING(-/-) bone marrow, are almost completely resistant to DMBA-induced skin carcinogenesis compared with their wild-type counterparts. Our data establish a role for STING in the control of cancer, shed significant insight into the causes of inflammation-driven carcinogenesis and may provide a basis for therapeutic strategies to help prevent malignant disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25300616      PMCID: PMC4998973          DOI: 10.1038/ncomms6166

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  25 in total

1.  Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis.

Authors:  C Gabler; N Blank; T Hieronymus; M Schiller; J H M Berden; J R Kalden; H-M Lorenz
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.

Authors:  Alevtina Gall; Piper Treuting; Keith B Elkon; Yueh-Ming Loo; Michael Gale; Glen N Barber; Daniel B Stetson
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

Review 4.  Autoimmunity and the clearance of dead cells.

Authors:  Shigekazu Nagata; Rikinari Hanayama; Kohki Kawane
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

5.  Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma.

Authors:  Badri G Modi; Jason Neustadter; Elisa Binda; Julia Lewis; Renata B Filler; Scott J Roberts; Bernice Y Kwong; Swapna Reddy; John D Overton; Anjela Galan; Robert Tigelaar; Lining Cai; Peter Fu; Mark Shlomchik; Daniel H Kaplan; Adrian Hayday; Michael Girardi
Journal:  Science       Date:  2012-01-06       Impact factor: 47.728

6.  Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.

Authors:  Lijun Sun; Jiaxi Wu; Fenghe Du; Xiang Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

7.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.

Authors:  Hiroki Ishikawa; Zhe Ma; Glen N Barber
Journal:  Nature       Date:  2009-09-23       Impact factor: 49.962

8.  STING manifests self DNA-dependent inflammatory disease.

Authors:  Jeonghyun Ahn; Delia Gutman; Shinobu Saijo; Glen N Barber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-06       Impact factor: 11.205

Review 9.  Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity.

Authors:  Takumi Kawasaki; Taro Kawai; Shizuo Akira
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

10.  IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis.

Authors:  Christophe Cataisson; Rosalba Salcedo; Shakeeb Hakim; B Andrea Moffitt; Lisa Wright; Ming Yi; Robert Stephens; Ren-Ming Dai; Lyudmila Lyakh; Dominik Schenten; H Stuart Yuspa; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2012-08-20       Impact factor: 14.307

View more
  137 in total

Review 1.  Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.

Authors:  Leticia Corrales; Thomas F Gajewski
Journal:  Clin Cancer Res       Date:  2015-09-15       Impact factor: 12.531

Review 2.  DNA Damage and Repair Biomarkers of Immunotherapy Response.

Authors:  Kent W Mouw; Michael S Goldberg; Panagiotis A Konstantinopoulos; Alan D D'Andrea
Journal:  Cancer Discov       Date:  2017-06-19       Impact factor: 39.397

3.  Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation.

Authors:  Qiaoshi Lian; Jun Xu; Shanshan Yan; Min Huang; Honghua Ding; Xiaoyu Sun; Aiwei Bi; Jian Ding; Bing Sun; Meiyu Geng
Journal:  Cell Res       Date:  2017-04-14       Impact factor: 25.617

4.  Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells.

Authors:  Jeonghyun Ahn; Tianli Xia; Ailem Rabasa Capote; Dillon Betancourt; Glen N Barber
Journal:  Cancer Cell       Date:  2018-04-26       Impact factor: 31.743

5.  STING Requires the Adaptor TRIF to Trigger Innate Immune Responses to Microbial Infection.

Authors:  Xin Wang; Tanmay Majumdar; Patricia Kessler; Evgeny Ozhegov; Ying Zhang; Saurabh Chattopadhyay; Sailen Barik; Ganes C Sen
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

Review 6.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

Review 7.  Activation and regulation of DNA-driven immune responses.

Authors:  Søren R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2015-06       Impact factor: 11.056

8.  Diverse roles of STING-dependent signaling on the development of cancer.

Authors:  J Ahn; H Konno; G N Barber
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

9.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

Review 10.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.